RNAI Drug Delivery Market Comprehensive Statistics, Growth Rate, and Future Trends 2035
RNA interference (RNAi) therapeutics offer selective gene silencing capability, yet effective delivery remains a major challenge due to double-stranded RNA instability and endosomal trap risks. Advancements in lipid nanoparticles (LNPs), GalNAc (N-acetylgalactosamine) conjugates, and polymeric carrier platforms have successfully unlocked clinical and commercial viability for siRNA drug...
